Current Guidelines for the Management of Branch Duct Intraductal Papillary Mucinous Neoplasms

摘要: The management of pancreatic cystic neoplasms has been constantly evolving and changing over the past 2 decades [1-3]. This is mainly due to rapid advancement knowledge in this field resulting particular: 1) improved understanding natural history biological behavior different pathological entities which comprise 2) more accurate preoperative diagnosis these as a result better their individual morphological characteristics on imaging introduction newer diagnostic modalities such endoscopic ultrasonography with fine needle aspirate (EUS-FNA) [2-4]. In general, approach trended from that aggressive surgical resection [5] selective whereby most are now managed via surveillance [1,6-8]. Since landmark paper by Compagno Oertel [9]; general consensus was all mucinous were potentially malignant or should be surgically resected whereas serous benign could conservatively [2,10,11]. Subsequently, investigators recognized actually composed distinct i.e. (MCNs) intraductal papillary (IPMNs) [10,12,13]. More recently, it IPMNs classified into branch-duct (BD), main-duct (MD) mixed-duct types (MT) [14,15]. BD-IPMNs found associated less when compared MD/MT-IPMN many have since demonstrated selected [1,6,8,14-16].